This crosstalk between HIF-1α and YAP underscores the complexity of cellular responses to hypoxia and suggests potential targets for therapeutic intervention in diseases such as cancer, where hypoxia and dysregulated Hippo signaling contribute to tumor progression. This evidence concerns the gene HIF1A and neoplasm.